Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activity

Pharmaceutical Research

Volumn 16, Issue 7, 1999, Pages 1067-1073

  Wasan, Kishor M ^a   Subramanian, Ramaswamy ^a   Chou, Jenny Wen Lin ^a   Ramaswamy, Manisha ^a   Pritchard, P Haydn ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclosporine; Lipid transfer protein l; Lipoproteins; Triglycerides

Indexed keywords

CYCLOSPORIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL TRANSPORT; CONCENTRATION (PARAMETERS); DRUG TRANSPORT; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; PLASMA; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CYCLOSPORINE; HUMANS; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENTS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; TRIGLYCERIDES; TRITIUM;

EID: 0032767083     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018991917799     Document Type: Article

References (31)

1. A. R. Tall, E. Abreau, and J. Shuman. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J. Biol. Chem. 258:2174-2178 (1983).
2. R. E. Morton and D. B. Zilversmit. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 23:1058-1067 (1982).
3. R. E. Morton and D. B. Zilversmit. Inter-relationships of lipid transferred by the lipid transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258:11751-11756 (1983).
4. R. E. Morton. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experimentia 46:552-560 (1990).
5. O. V. Rajaram, G. H. White, and P. J. Barter. Partial purification and characterization of a triacylglycerol-transfer protein from rabbit serum. Biochim. Biophys. Acta. 617:383-390 (1980).
6. A. S. Jarnagin, W. Kohr, and C. Fielding. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc. Natl. Acad. Sci. USA 84:1854-1860 (1987).
7. J. J. Albers, J. H. Tollefson, C-H Chen, and A. Steinmetz. Isolation and characterization of human lipid transfer proteins. Arteriosclerosis 4:49-58 (1984).
8. K. M. Wasan, M. Ramaswamy, W. Wong, and P. H. Pritchard. Lipid transfer protein I facilitated transfer of cyclosporine from low-to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity. J. Pharmacol Exp. Ther. 284:599-605 (1998).
9. K. M. Wasan and S. M. Cassidy. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J. Pharm. Sci. 87:411-424 (1998).
10. K. M. Wasan, P. H. Pritchard, M. Ramaswamy, W. Wong, E. M. Donnachie, and L. J. Brunner. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 14:1613-1620 (1997).
11. J. Nemunaitis, H. J. Deeg, and G. C. Yee. High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridemia. Lancet i:744-745 (1986).
12. N. De Kippel, J. Sennesael, J. Lamote, G. Ebinger, and J. De Keyser. Cyclosporin leukoencephalopathy induced by intravenous lipid solution. Lancet 339:1114-1115 (1992).
13. P. C. de Groen, A. J. Aksamit, J. Rakela, G. S. Forbes, and R. A. F. From. Central nervous system toxicity after liver transplantation. N. Eng. J. Med. 317:861-866 (1987).
14. M. Lemaire, W. M. Pardridge, and G. Chaudhuri. Influence of blood components on the tissue uptake indices of cyclosporin in rats. J. Pharmacol. Exp. Ther. 244:740-743 (1988).
15. W. M. Pardridge. Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 64:145-154 (1979).
16. A. M. Gardier, D. Mathe, X. Guedeney, J. Barre, C. Benvenutti, N. Navarro, L. Vernillet, D. Loisance, J. P. Cachera, B. Jacotot, and J. P. Tillement. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther. Drug Monit. 15:274-280 (1993).
17. M. Arnadottir, H. Thysell, and P. Nilsson-Ehle. Lipoprotein levels and post-heparin lipase activities in kidney transplant recipients: Ciclosporin-versus non-ciclosporin-treated patients. Am. J. Kidney Dis. 17:700-717 (1991).
18. P. Moulin, G. B. Appel, H. N. Ginsberg, and A. R. Tall. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J. Lipid Res. 33:1817-1822 (1992).
19. M. Ramaswamy, X. Zhang, H. M. Burt, and K. M. Wasan. The human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. J. Pharm. Sci. 86:460-464 (1997).
20. R. J. Havel, H. A. Eder, and J. H. Bragdon. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345-1353 (1955).
21. K. M. Wasan, S. M. Cassidy, M. Ramaswamy, A. Kennedy, F. W. Strobel, S. P. Ng, and T. Y. Lee. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. Pharm. Res. 16:165-169 (1999).
22. M. Burstein, H. R. Scholnick, and R. Morfin. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11:583-595 (1970).
23. K. M. Wasan, R. E. Morton, M. G. Rosenblum, and G. Lopez-Berestein. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high density lipoproteins: Role of lipid transfer protein. J. Pharm. Sci. 83:1006-1010 (1994).
24. N. M. Pattnaik and D. B. Zilversmit. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J. Biol. Chem. 254:2782-2786 (1979).
25. L. J. Brunner, D. R. Luke, J. Lautersztain, et al. Single-dose cyclosporine pharmacokinetics in various biological fluids of patients receiving allogenic bone marrow transplantation. Ther. Drug Monit. 12:134-138 (1990).
26. H. R. Betschart, W. R. Jondorf, and M. H. Bickel. Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration. Xenobiotica 18:113-121 (1988).
27. C. B. Hesler, A. R. Tall, T. L. Swenson, P. K. Weech, Y. L. Marcel, and R. W. Milne. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263:5020-5023 (1988).
28. K. M. Wasan, G. A. Brazeau, A. Keyhani, A. C. Hayman, and G. Lopez-Berestein. Role of liposome composition and temperature on the distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 37:246-250 (1993).
29. J. Bolard, M. Seigneuret, and G. Boudet. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Lipid State and cholesterol content dependence. Biochim. Biophys. Acta. 599:280-293 (1980).
30. D. Sgoutas, W. MacMahon, A. Love, and I. Jerkunica. Interaction of cyclosporine A with human lipoproteins. J. Pharm. Pharmacol. 38:583-588 (1986).
31. R. B. Shireman and J. F. Remsen. Imipramine associations with plasma components and its uptake by cultured human cells. Life Sci. 33:2165-2171 (1983).